29 Skin Cancer

Skin Cancer

18

THE GEC ESTROHANDBOOKOF BRACHYTHERAPY | Part II Clinical Practice Version 1 - 30/04/2017

15. REFERENCES

22. Semrau S, Kunz M, Baggesen K, et al. Successful treatment of field cancerization of the scalp by surface mould brachytherapy. Br J Dermatol 2008; 159:753-5. 23. Sachse MM, Wagner G, Aydin H, et al. Treatment of extensive lentigo maligna melanoma of the scalp by brachytherapy moulage technique. Br J Dermatol 2011; 164:219-21. 24. van der Laarse R. The stepping source dosimetry system as an extension of the Paris system. Chapter 34. In “Brachytherapy from radium to Optimization”. Editors: Mould RF, Battermann JJ, Martinez AA, Speiser BL. 1994. Published by Nucletron. 25. Demanes DJ, Friedman JM, Park SJ, et al. Brachytherapy catheter spacing and stabilization technique. Brachytherapy . 2012; 11:392-7. 26. Rivard MJ, Coursey BM, DeWerd LA, et al. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. Med . Phys 2004; 31:663-674. 27. Granero D, Perez-Calatayud J, Vijande J, Ballester F, Rivard MJ. Limitations of the TG-43 formalism for skin high-dose-rate brachytherapy dose calculations. Med Phys 2014; 41(2):021703. 28. Dutreix A, Wambersie A, Marinello G: Dosimétrie en curiethérapie. Masson, Paris, 1982 29. Major T., Polgar C., Somogyi R, Nemeth G. Evaluation of the dose uniformity for double plane high dose rate interstitial breast implants with the use of dose reference points and dose non-uniformity ratio. Radiotherapy and Oncology 2000; 54:213-220. 30. Crook JM, Mazeron JJ, Marinello G, et al. Interstitial Iridium 192 for cutaneous carcinoma of the external nose. Int J Radiat Oncol Biol Phys 1990; 18: 243-48. 31. Debois JM. Cesium-137 brachytherapy for epithelioma of the skin of the nose: experience with 370 patients. JBR-BTR 1994; 77: 1-4. 32. Mazeron JJ, Chassagne D, Crook J, et al. Radiation therapy of carcinomas of the skin of nose and nasal vestibule: A report of 1676 cases by the Groupe Europeen de Curiethérapie. Radiother Oncol 1988; 13: 165-73 33. Baris G, Visser AG, van Andel JG. The treatment of squamous cell carcinoma of the nasal vestibule with interstitial iridium implantation. Radiother Oncol 1985; 4: 121-25. 34. Daly NJ, de Lafontan B, Combes PF. Results of the treatment of 165 lid carcinomas by iridium wire implant. Int J Radiat Oncol Biol Phys 1984; 10: 455-59. 35. Gambaro G, Negri E, Prino, et al. Interstitial brachytherapy with Iridium-192 for carcinomas of the eyelid and inner canthus. Radiother Oncol 2001; 60 (suppl.1): 16. 36. Mazeron JJ, Ghalie R, Zeller J, et al. Radiation therapy for carcinoma of the pinna using iridium 192 wires: a series of 70 patients. Int J Radiat Oncol Biol Phys 1986; 12: 1757-63. 37. Maes A, Van Limbergen. E. LDR – Brachytherapy (BT) for non-melanoma skin cancer of the face: Local control rate, functional and cosmetic outcome in 173 patients. Radiother Oncol 2001; 60 (suppl 1): 16. 38. Rio E, Bardet E, Ferron C, et al. Interstitial brachytherapy of periorificial skin carcinomas of the face: A restrospective study of 97 cases. Int Radiat Oncol Biol Phys 2005;63:753-757. 39. Ducassou A, David I, Filleron T, et al. Retrospective analysis of local control and cosmetic outcome of 147 periorificial carcinomas of the face treated with low-dose rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys 2011; 81:726-31. 40. Mosterd K, Krekels GA, Nieman FH, et al. Surgical excision versus Mohs’ micrographic surgery for primary and recurrent basal-cell carcinoma of the face: A prospective randomised controlled trial with 5-years’ follow-up. Lancet Oncol 2008;9:1149-1156. 41. Lansbury L, Leonardi-Bee J, Perkins W, et al. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev 2010;4: CD007869. 42. Svoboda VH, Kovarik J, Morris F. High dose-rate microselectron molds in the treatment of skin tumors. Int J Radiat Oncol Biol Phys . 1995 Feb 15;31(4):967- 72.

1. Rogers HW, et al, Incidence estimate of non-melanoma skin cancer in the United States, 2006. Arch Dermatol , 2010; 146 (3): 283-287. 2. Bath-Hextall FJ1, Perkins W, Bong J, Williams HC. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev . 2007; (1):CD003412. 3. Avril M-F, Auperin A, Gerbaulet A, et al. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer 1997; 76: 100-6. 4. Ouhib Z, Kasper M, Perez-Calatayud J et al. Aspects of dosimetry and clinical practice of skin brachytherapy: The American Brachytherapy Society working group report. Brachytherapy 2015; 14(6): 840-58. 5. Mendenhall WM, Million RR, Mancuso AA, et al. Carcinoma of the skin. In: Million RR, Cassisi NJ, eds. Management of Head and Neck Cancer. A Multidisciplinary Approach. Philadelphia: J.B.Lippincott Company 1994; 643- 91 6. Ballester R, Pons O, Llavador M et al. Depth determination of skin cancers treated with superficial brachytherapy: ultrasound vs histopathology. J Contemp Brachyther 2014; 6(4): 417-423. 7. Alam M, Nanda S, Mittal BB, Kim NA, Yoo S. The use of brachytherapy in the treatment of non-melanoma skin cancer: a review. J Am Acad Dermatol. 2011; 65(2):377-88. 8. Sabbas AM, Kulidzhanov FG, Presser J, et al. HDR Brachytherapy with surface applicators: Technical considerations and dosimetry. Technol Cancer Res Treat 2004;3:259-267. 9. Evans MDC, Yassa M, Podgorsak EB, Roman TN, Schreiner LJ, Souhami L. Surface applicators for high dose rate brachytherapy in aids-related Kaposı sarcoma. Int J Radiat Oncol Biol Phys 1997;39:769-74. 10. Hwang IM, Lin SY, Lin LC, Chuang KS, Ding HJ. Alternative effective modality of Leipzig applicator with an electron beam for the treatment of superficial malignancies. Nuc Inst Meth A 2003;508:460-6. 11. Niu H, His WC, Chu JCH, Kirk MC. Dosimetric characteristics of the Leipzig surface applicators used in the high dose rate brachytherapy. Med Phys 2004;31:3372-7 12. Perez-Calatayud J, Granero D, Ballester F, Puchades V, Casal E, Soriano A, et al. A dosimetric study of the Leipzig applicators. Int J Rad Oncol Biol Phys 2005; 62:579-84. 13. Granero D, Perez-Calatayud J, Jimeno J, et al. Design and evaluation of a HDR skin applicator with flattening filter. Med Phys 2008; 35:495-503. 14. Granero D, Perez-Calatayud J, Ballester F, Ouhib Z. Radiation leakage study for the Valencia applicators. Phys Med . 2013; 29:60-4. 15. Candela-Juan C, Niatsetski Y, van der Laarse R,et al. Design and characterization of a new high-dose-rate brachytherapy Valencia applicator for larger skin lesions. Medical Physics 2016; 43(4):1639-1648. 16. Fulkerson, R.K., Dosimetric characterization of surface applicators for use with high dose rate Ir-192 and electronic brachytherapy sources, 2012, University of Wisconsin-Madison. p. 165. 17. Rong Y, Welsh JS. Surface applicator calibration and commissioning of an electronic brachytherapy system for non-melanoma skin cancer and treatment. Med Phys 2010; 37: 5509-5517. 18. Bhatnagar A. Nonmelanoma skin cancer treated with electronic brachytherapy: Results at 1 year. Brachytherapy 2013; 12: 134-140. 19. Garcia-Martinez T, Chan JP, Perez-Calatayud J, Ballester F. Dosimetric characteristics of a new unit for electronic skin brachytherapy. J Contemp Brachyther 2014; 6(1) 1-9. 20. Vijande J, Ballester F, Ouhib Z, Granero D, Pujades-Claumarchirant MC, Perez-Calatayud J. Dosimetry comparison between TG-43 and Monte Carlo calculations using the Freiburg flap for skin high-dose-rate brachytherapy. Brachytherapy 2012; 11:528-35. 21. Ozyar E, Gurdalli S. Mold brachytherapy can be an optional technique for total scalp irradiation. Int Radiat Oncol Biol Phys . 2002; 54:1286.